Info_Otros-Programas-Internacionales

OTHER INTERNATIONAL PROGRAMMES AND FOUNDATIONS

**NARSAD - Brain and Behavior Research Foundation**
Summary	The Brain & Behavior Research Foundation is committed to alleviating the suffering caused by mental illness by awarding grants that will lead to advances and breakthroughs in scientific research.
Objetive	The focus of this foundation is to understand, prevent, and treat brain and behavioral disorders including autism, anxiety, depression, and others.
Modality	There are three funding types as follows: Young Investigator Grants • For investigators at the post-doctoral or assistant professor level. • Two-year awards of US$35.000/year for pilot projects. • Annual call for applications in January-February Independent Investigator Grants • For independent researchers at the associate professor level. • Two-year awards of US$50.000/year. • Annual call for applications in November-December Distinguished Investigator Grants • For the full professor level. • One-year awards of US$100.000 • Annual call for applications in June-July
Link	https://bbrfoundation.org/grants

**European Molecular Biology Organisation (EMBO)**
Summary	EMBO is an organization that promotes excellence in life science careers, with an emphasis on molecular biology.
Objetive	EMBO helps young scientists to advance their research, promote their international reputations and ensure their mobility. Courses, workshops, conferences and EMBO Press publications disseminate the latest research and offer training in techniques to maintain high standards of excellence in research practice. EMBO helps to shape science policy by seeking input and feedback from our community and by following closely the trends in science in Europe.
Modality	It provides support through the following mechanisms: Short-Term and Long-Term, and European Respiratory Society (ERS) Fellowships • Intended for postdoctoral-level researchers • Funding to return to a home lab (short-term), to work abroad (long-term), or to recruit more respiratory clinicians into research (ERS) • Application deadlines: Ongoing (short-term); annually, February 12 and August 12 (long-term); and annually, January, April, and October (ERS) Young Investigators: • For the assistant professor level • Funding of 15.000€ and an extensive network of opportunities for mentoring and professional development. • Annual application deadline, April 1 Travel and Lecture Grants • Funding to attend or organize EMBO events
Link	http://www.embo.org/funding-awards

**U.S. National Institutes of Health (NIH)**
Summary	The U.S. National Institutes of Health fund a wide variety of biomedical projects in fields such as cancer biology, vaccine development, mental health biology, drug and alcohol addiction treatments, bioinformatics, and many more, with new opportunities announced weekly.
Objetive	Non-U.S.-based research groups must either provide evidence that they can contribute a unique resource that is not available in the U.S. (e.g., a unique collection of samples) OR they may act as the sub-contractor of a U.S.-based collaborator.
Modality	NIH offers funding for many types of grants, contracts, and programs.
Link	https://grants.nih.gov/grants/guide/index.html

**Worldwide Cancer Research**
Summary	Translational cancer research
Objetive	This foundation provides financing for projects that could reduce the incidence of cancer or improve cancer survival.
Modality	Projects of 12-36 months will be funded for up to 250.000 £. Applications are due annually in April or October.
Link	http://www.worldwidecancerresearch.org/funding/make-an-application

For more information: proyectoseuropeos@ehu.eus

Life Sciences Projects

Vaccines that Replicate Neutralization- Competent Structures within the Membrane Proximal External Region of HIV1-gp41

NIH-CIH project

Specific programme: U.S. National Institutes of Health and the Canadian Institutes of Health Research
UPV/EHU Partner Status: Consortium Partner
UPV/EHU Supervisor: Jose Luis Nieva Escandon
Project start: 01/10/2011
Project end: 28/02/2018

Brief description: The goal is to produce a vaccine lead for all types of HIV-1 infection, and as such, it is of relevance to all of the key populations targeted by CIHR¿s HIV/AIDS Research Initiative. The investigators seek to produce a vaccine that will mimic the structure of the membrane proximal external region of gp41 (MPER) as it exists on the virus; by mimicking the neutralization-competent structure of the MPER, with the expectation of producing a vaccine that elicits antibodies that will bind to the MPER on the virus and block it from successfully infecting cells.